A ruptured gastrointestinal stromal tumour of the small intestine: a case report

A ruptured gastrointestinal stromal tumour of the small intestine: a case report

Authors

  • Ivan Lolli Oncologia Medica, IRCCS Saverio de Bellis, Castellana Grotte (BA)
  • Sergio Diotaiuti Chirurgia Generale C. Righetti, Policlinico Bari
  • Silvana Russo Anatomia Patologica, Policlinico Bari
  • Giovanna A. Campanella Oncologia Medica, IRCCS Saverio de Bellis, Castellana Grotte (BA)
  • Nicola Giampaolo Anatomia Patologica, Policlinico Bari
  • Gioacchino Leandro Gastroenterologia, IRCCS Saverio de Bellis, Castellana Grotte (BA)
  • Vincenzo Defilippis Oncologia Medica, IRCCS Saverio de Bellis, Castellana Grotte (BA)

DOI:

https://doi.org/10.7175/cmi.v5i1S.1101

Keywords:

Ruptured gastrointestinal stromal tumour (GIST), Small intestine, Adjuvant imatinib

Abstract

The management of Gastrointestinal Stromal Tumours (GISTs) has evolved rapidly since imatinib was introduced. Surgery remains the first-line treatment for localised, primary GIST, but the risk for local or metastatic relapse of disease is very high. Prognostic assessment is a critical part of developing a treatment strategy. Perforation or rupture of a GIST to the abdominal cavity has a very high risk for recurrence. We described the case of a 51-year-old man with a haemoperitoneum caused by a ruptured primary GIST of the small intestine. After complete surgical resection, imatinib given for two years as adjuvant therapy achieved no disease progression after prolonged follow-up.

Downloads

Published

2015-10-13

Issue

Section

Case report
Loading...